We are representing biotech company Dendreon Corporation in its Chapter 11 reorganization, announced November 10, in the U.S. Bankruptcy Court for the District of Delaware.
We are representing biotech company Dendreon Corporation in its Chapter 11 reorganization, announced November 10, in the U.S. Bankruptcy Court for the District of Delaware.